Marinomed has already achieved many milestones in its short history. The selected scientific publications and press releases provide information on the most important events to date.
November 16, 2018
Marinomed determines IPO timeline and terms
November 05, 2018
Marinomed intends to conduct an IPO on the Vienna Stock Exchange
October 19, 2018
Initiation of Phase III clinical trial
August 29, 2018
Vienna-based biotech company Marinomed on a growth path
August 07, 2018
Vienna-based Biotech Company Marinomed obtains EU-wide Certification for new cold Medication
July 31, 2018
Pascal Schmidt appointed CFO as Vienna based biotech firm Marinomed strengthens its management team – Company reports strong growth.
November 27, 2017